论文部分内容阅读
1文献来源Yue DS,Xu SD,Wang Q,et al.Erlotinib versus Vinorelbine plus Cisplatin as adjuvant therapy in Chinese patients with stage Ⅲ A EGFR mutation-positive non-small-cell lung cancer(EVAN):A randomised,open-label,phase 2 trial[J].Lancet Respir Med,2018,6(11)